Tysabri Clinical Trials Tysabri RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
Condition:   Multiple Sclerosis, Relapsing-Remitting Intervention:   Drug: Natalizumab Injection [Tysabri] Sponsors:   University Hospital, Caen;   Biogen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials